Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL11668304 | 1.00 | ALDH1A1 (0.42) | ALDH1A1HPGDKDM4EGAAKMT2A | |
| Tetraethylene Glycol SCHEMBL2219623 | 0.94 | ALDH1A1 (0.46) | ALDH1A1HPGDGAAKMT2ARECQL | |
| Triethylene Glycol SCHEMBL8163221 | 0.94 | ALDH1A1 (0.46) | ALDH1A1HPGDGAAKMT2ARECQL | |
| Triethylene Glycol SCHEMBL10383178 | 0.88 | ALDH1A1 (0.42) | ALDH1A1HPGDKDM4EGAAKMT2A | |
| Ether SCHEMBL16685384 | 0.87 | GAA (0.45) | ALDH1A1HPGDKDM4EGAAKMT2A | |
| Di(Hydroxyethyl)Ether SCHEMBL11668306 | 0.87 | ALDH1A1 (0.43) | ALDH1A1HPGDKDM4EGAAKMT2A | |
| Triethylene Glycol SCHEMBL11674048 | 0.85 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EGAAKMT2A | |
| Ethylene Glycol SCHEMBL27552267 | 0.82 | GAA (0.46) | ALDH1A1GAAKMT2ARECQLSMN1; SMN2 | |
| SCHEMBL23727060 | 0.82 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EGAAKMT2A | |
| Diethylene Glycol Monoethyl Ether SCHEMBL11273546 | 0.82 | ALDH1A1 (0.44) | ALDH1A1HPGDKDM4EGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113248352-B | Method for synthesizing heptaglyme through solid phase | 长沙创新药物工业技术研究院有限公司 | 2024-08-13 | — | — | CN | claimed |
| CN-113248352-A | Method for solid-phase synthesis of heptaethylene glycol monomethyl ether | 湖南华腾制药有限公司 | 2021-08-13 | — | — | CN | claimed |
| CN-110734450-A | hydrogen sulfide fluorescent probes and preparation method and application thereof | 贺州学院 | 2020-01-31 | — | — | CN | claimed |
| CN-113248352-B | Method for synthesizing heptaglyme through solid phase | 长沙创新药物工业技术研究院有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-114573428-B | Organic conjugated molecule containing branched ether chain, preparation and application thereof | 北京大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-115594636-B | N-heterocyclic carbene ligand, N-heterocyclic carbene ruthenium complex, and synthesis method and application thereof | 西华大学 | 2023-07-25 | — | — | CN | disclosed |
| US-11649253-B2 | Terbium and dysprosium complexes with optimised antenna, used as luminescent markers | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2023-05-16 | — | — | US | disclosed |
| CN-115594636-A | N-heterocyclic carbene ligand, N-heterocyclic carbene ruthenium complex, and synthesis method and application thereof | 西华大学（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-114573428-A | Organic conjugated molecule containing branched ether chain, preparation and application thereof | 北京大学 | 2022-06-03 | — | — | CN | disclosed |
| CN-113248352-A | Method for solid-phase synthesis of heptaethylene glycol monomethyl ether | 湖南华腾制药有限公司 | 2021-08-13 | — | — | CN | disclosed |
| EP-3649214-B1 | TERBIUM AND DYSPROSIUM COMPLEXES WITH OPTIMISED ANTENNA, USED AS LUMINESCENT MARKERS | ECOLE NORMALE SUPERIEURE LYON (FR) | 2021-03-17 | — | — | EP | disclosed |
| US-20030055032-A1 | Peroxynitrite decomposition catalysts and methods of use thereof | NATIONAL INSTITUTES OF HEALTH | 2003-03-20 | — | — | US | disclosed |
| US-6448239-B1 | PORPHYRIN RING METALLIC COMPLEXES THAT ARE EFFECTIVE PEROXYNITRITE DECOMPOSITION CATALYSTS FOR TREATMENT OF DISEASES INVOLVING THE ACCUMULATION OF THIS OXIDANT, SUCH AS ALTZEIMER'S DISEASE | TRUSTEES OF PRINCETON UNIVERSITY | 2002-09-10 | — | — | US | disclosed |
| US-6375930-B2 | PARAMAGNETISM, PHOTOSENSITIVITY; IMAGING, DIAGNOSIS, DRUG DELIVERY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-04-23 | — | — | US | disclosed |
| US-20020006378-A1 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS, INC. | 2002-01-17 | — | — | US | disclosed |
| US-6207660-B1 | Texaphyrin conjugates and uses thereof | PHARMACYCLICS, INC. | 2001-03-27 | — | — | US | disclosed |
| EP-1082138-A1 | TEXAPHYRIN CONJUGATES AND USES THEREOF | THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999062551-A1 | TEXAPHYRIN CONJUGATES AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0954336-A2 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS, INC. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1997046262-A2 | MEMBRANE INCORPORATION OF TEXAPHYRINS | PHARMACYCLICS, INC. (US) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649253-B2 | Terbium and dysprosium complexes with optimised antenna, used as luminescent markers | SSB, TACR3, MAL2 | ALDH1A1 4594/4885HPGD 3366/4885KDM4E 4758/4885 |
| US-20030055032-A1 | Peroxynitrite decomposition catalysts and methods of use thereof | NOX3, MPO, CAT | ALDH1A1 669/4885HPGD 84/4885KDM4E 3098/4885 |
| US-20020006378-A1 | MEMBRANE INCORPORATION OF TEXAPHYRINS | CD47, PHOSPHO1, TEX13A | ALDH1A1 3912/4885HPGD 1939/4885KDM4E 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.